Plasma-based S100B testing for management of traumatic brain injury in emergency setting

BACKGROUND: Serum biomarker S100B has been explored for its potential benefit to improve clinical decision-making in the management of patients suffering from traumatic brain injury (TBI), especially as a pre-head computed-tomography screening test for patients with mild TBI. Although being already...

Descripción completa

Detalles Bibliográficos
Autores principales: Haselmann, Verena, Schamberger, Christian, Trifonova, Feodora, Ast, Volker, Froelich, Matthias F., Strauß, Maximilian, Kittel, Maximilian, Jaruschewski, Sabine, Eschmann, David, Neumaier, Michael, Neumaier-Probst, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141926/
https://www.ncbi.nlm.nih.gov/pubmed/34041343
http://dx.doi.org/10.1016/j.plabm.2021.e00236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141926/
https://www.ncbi.nlm.nih.gov/pubmed/34041343
http://dx.doi.org/10.1016/j.plabm.2021.e00236

Ejemplares similares